First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors.

Cite this paper

@article{Razak2016FirstinClassFP, title={First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors.}, author={Albiruni Ryan Abdul Razak and Morten Mau-Soerensen and Nashat Y Gabrail and John F. Gerecitano and Anthony Frank Shields and Thaddeus John Unger and Jean R Saint-Martin and Robert W. Carlson and Yosef Landesman and Dilara McCauley and Tami Rashal and Ulrik Niels Lassen and Richard D. Kim and L G Stayner and Mansoor Mirza and Michael G. Kauffman and Sharon Shacham and Amit Mahipal}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2016}, volume={34 34}, pages={4142-4150} }